Skip to main content
OpenTrials

Clinical trial condition

Mesothelioma

Explore clinical trials studying Mesothelioma. Study availability and eligibility vary by location and protocol.

189 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Mesothelioma trial results

Completed

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03071757

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +58 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 201334 La Jolla, California, United States
  • University of California, Davis Comprehensive Cancer Center /ID# 201342 Sacramento, California, United States
  • Stanford University /ID# 206949 Stanford, California, United States
  • Yale University /ID# 207895 New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Completed

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

NCT03000257

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +56 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 157374 La Jolla, California, United States
  • The University of Chicago Medical Center /ID# 157375 Chicago, Illinois, United States
  • Carolina BioOncology Institute /ID# 157376 Huntersville, North Carolina, United States
  • South Texas Accelerated Research Therapeutics /ID# 157378 San Antonio, Texas, United States
View all 26 locations
View Trial Details
Completed

A Study of LY3023414 in Participants With Advanced Cancer

NCT01655225

Conditions
Adenoma, Advanced Cancer, Breast Diseases, +35 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Peggy and Charles Stephenson Oklahoma Cancer Center Oklahoma City, Oklahoma, United States
  • Penn Presbyterian Medical Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

NCT02460224

Conditions
Adenoma, Advanced Solid Tumors, Bronchial Neoplasms, +31 more
Locations
  • Columbia University Medical Center SC LAG X2101C New York, United States
  • Memorial Sloan Kettering Cancer Center SC New York, United States
  • Duke Clinical Research Institute SC Durham, North Carolina, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 24 locations
View Trial Details

Related conditions